Trials / Recruiting
RecruitingNCT06124508
PromotinG Lung Cancer screenIng Awareness and Implementation in Hispanics/Latinx Head and Neck canceR Survivors
GUIAR: PromotinG Lung Cancer screenIng Awareness and Implementation in Hispanics/Latinx Head and Neck canceR Survivors
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 44 (estimated)
- Sponsor
- University of Miami · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the awareness of eligibility of lung cancer screening in Hispanic/LatinX Head and Neck Cancer (HNC) survivors using a survey questionnaire; and to understand the barriers to screening using qualitative interviews.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Lung Cancer Screening Education | Tailored lung cancer screening education will consist of an annual, in-person 60 minute visit of lung cancer screening education in the participant's native language with material in layman's terms about the importance of lung cancer screening, tobacco cessation, and the risk of developing a second primary lung cancer. |
| BEHAVIORAL | Semi-Structured Interview | Participants will undergo an annual, in-person or virtual, semi-structured interviews to understand barriers and perception towards screening and cultural competencies to increase adherence to lung cancer screening. The interviews will last approximately 30 minutes at each visit. |
| BEHAVIORAL | Standard of Care Lung Cancer Screening Program | Participants will receive standard of care referral to the University of Miami's Lung Cancer Screening Program. The standard education includes a one-time, in-person or virtual 60-minute visit with the Advanced Practice Registered Nurse (APRN) to review educational material about lung cancer screening and tobacco cessation guidelines, and to discuss the risks versus benefits of undergoing screening. |
Timeline
- Start date
- 2024-04-11
- Primary completion
- 2026-04-30
- Completion
- 2026-04-30
- First posted
- 2023-11-09
- Last updated
- 2025-04-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06124508. Inclusion in this directory is not an endorsement.